Drug Discovery Services Market
Drug Discovery Services Market Analysis by Process (Target Selection, Target Validation, Hit-To-Lead Identification), by Type (Medicinal Chemistry, Biology Services, Pharmacokinetics), by Drug Type (Small Molecules and Biologics) by Therapeutic Area, by Region - Global Market Insights 2022-2032
Analysis of Drug Discovery Services market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Table of Content
1. Global Economic Outlook 2. Global Drug Discovery Services Market - Executive Summary 3. Global Drug Discovery Services Market Overview 3.1. Introduction 3.1.1. Global Drug Discovery Services Market Taxonomy 3.1.2. Global Drug Discovery Services Market Definition 3.2. Global Drug Discovery Services Market Size (US$ Mn) and Forecast, 2015-2032 3.2.1. Global Drug Discovery Services Market Y-o-Y Growth 3.3. Global Drug Discovery Services Market Dynamics 3.4. Supply Chain 3.5. Cost Structure 3.6. PESTL Analysis 3.7. Product Life Cycle Analysis 3.8. Drug Discovery & Development Process 3.9. Roadmap to Optimize Regulatory and Commercial Success 3.10. Evolution of R&D Drug Discovery Outsourcing 3.11. Service Provider List 3.12. Key Participants Market Presence (Intensity Map) By Region 4. Global Drug Discovery Services Market Analysis and Forecast 2015-2032 4.1. Global Drug Discovery Services Market Size and Forecast by Process, 2015-2032 4.1.1. Target Selection Market Size and Forecast, 2015-2032 4.1.1.1. Revenue (US$ Mn) Comparison, By Region 4.1.1.2. Market Share Comparison, By Region 4.1.1.3. Y-o-Y growth Comparison, By Region 4.1.2. Target Validation Market Size and Forecast, 2015-2032 4.1.2.1. Revenue (US$ Mn) Comparison, By Region 4.1.2.2. Market Share Comparison, By Region 4.1.2.3. Y-o-Y growth Comparison, By Region 4.1.3. Hit-To-Lead Identification Market Size and Forecast, 2015-2032 4.1.3.1. Revenue (US$ Mn) Comparison, By Region 4.1.3.2. Market Share Comparison, By Region 4.1.3.3. Y-o-Y growth Comparison, By Region 4.1.4. Lead Optimization Market Size and Forecast, 2015-2032 4.1.4.1. Revenue (US$ Mn) Comparison, By Region 4.1.4.2. Market Share Comparison, By Region 4.1.4.3. Y-o-Y growth Comparison, By Region 4.1.5. Candidate Validation Market Size and Forecast, 2015-2032 4.1.5.1. Revenue (US$ Mn) Comparison, By Region 4.1.5.2. Market Share Comparison, By Region 4.1.5.3. Y-o-Y growth Comparison, By Region 4.2. Global Drug Discovery Services Market Size and Forecast By Type, 2015-2032 4.2.1. Medicinal Chemistry Market Size and Forecast, 2015-2032 4.2.1.1. Revenue (US$ Mn) Comparison, By Region 4.2.1.2. Market Share Comparison, By Region 4.2.1.3. Y-o-Y growth Comparison, By Region 4.2.2. Biology Services Market Size and Forecast, 2015-2032 4.2.2.1. Revenue (US$ Mn) Comparison, By Region 4.2.2.2. Market Share Comparison, By Region 4.2.2.3. Y-o-Y growth Comparison, By Region 4.2.3. Drug Metabolism and Pharmacokinetics Market Size and Forecast, 2015-2032 4.2.3.1. Revenue (US$ Mn) Comparison, By Region 4.2.3.2. Market Share Comparison, By Region 4.2.3.3. Y-o-Y growth Comparison, By Region 4.3. Global Drug Discovery Services Market Size and Forecast By Drug Type, 2015-2032 4.3.1. Small Molecules Market Size and Forecast, 2015-2032 4.3.1.1. Revenue (US$ Mn) Comparison, By Region 4.3.1.2. Market Share Comparison, By Region 4.3.1.3. Y-o-Y growth Comparison, By Region 4.3.2. Biologics Market Size and Forecast, 2015-2032 4.3.2.1. Revenue (US$ Mn) Comparison, By Region 4.3.2.2. Market Share Comparison, By Region 4.3.2.3. Y-o-Y growth Comparison, By Region 4.4. Global Drug Discovery Services Market Size and Forecast By Therapeutic Area, 2015-2032 4.4.1. Oncology Market Size and Forecast, 2015-2032 4.4.1.1. Revenue (US$ Mn) Comparison, By Region 4.4.1.2. Market Share Comparison, By Region 4.4.1.3. Y-o-Y growth Comparison, By Region 4.4.2. Neurology Market Size and Forecast, 2015-2032 4.4.2.1. Revenue (US$ Mn) Comparison, By Region 4.4.2.2. Market Share Comparison, By Region 4.4.2.3. Y-o-Y growth Comparison, By Region 4.4.3. Respiratory Diseases Market Size and Forecast, 2015-2032 4.4.3.1. Revenue (US$ Mn) Comparison, By Region 4.4.3.2. Market Share Comparison, By Region 4.4.3.3. Y-o-Y growth Comparison, By Region 4.4.4. Respiratory Diseases Market Size and Forecast, 2015-2032 4.4.4.1. Revenue (US$ Mn) Comparison, By Region 4.4.4.2. Market Share Comparison, By Region 4.4.4.3. Y-o-Y growth Comparison, By Region 4.4.5. Diabetes Market Size and Forecast, 2015-2032 4.4.5.1. Revenue (US$ Mn) Comparison, By Region 4.4.5.2. Market Share Comparison, By Region 4.4.5.3. Y-o-Y growth Comparison, By Region 4.4.6. Other Therapeutic Areas Market Size and Forecast, 2015-2032 4.4.6.1. Revenue (US$ Mn) Comparison, By Region 4.4.6.2. Market Share Comparison, By Region 4.4.6.3. Y-o-Y growth Comparison, By Region 5. North America Drug Discovery Services Market Size and Forecast, 2015-2032 5.1. North America Outlook 5.2. North America Parent Market Outlook 5.3. North America Target Market Outlook 5.4. Revenue (US$ Mn) Comparison, By Country 5.4.1. US Market Size and Forecast (US$ Mn), 2015-2032 5.4.2. Canada Market Size and Forecast (US$ Mn), 2015-2032 5.5. Revenue (US$ Mn) Comparison, By Process 5.6. Revenue (US$ Mn) Comparison, By Type 5.7. Revenue (US$ Mn) Comparison, By Drug Type 5.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 6. Latin America Drug Discovery Services Market Size and Forecast, 2015-2032 6.1. Latin America Outlook 6.2. Latin America Parent Market Outlook 6.3. Latin America Target Market Outlook 6.4. Revenue (US$ Mn) Comparison, By Country 6.4.1. Brazil Market Size and Forecast (US$ Mn), 2015-2032 6.4.2. Mexico Market Size and Forecast (US$ Mn), 2015-2032 6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2015-2032 6.5. Revenue (US$ Mn) Comparison, By Process 6.6. Revenue (US$ Mn) Comparison, By Type 6.7. Revenue (US$ Mn) Comparison, By Drug Type 6.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 7. Europe Drug Discovery Services Market Size and Forecast, 2015-2032 7.1. Europe Outlook 7.2. Europe Parent Market Outlook 7.3. Europe Target Market Outlook 7.4. Revenue (US$ Mn) Comparison, By Country 7.4.1. Germany Market Size and Forecast (US$ Mn), 2015-2032 7.4.2. UK Market Size and Forecast (US$ Mn), 2015-2032 7.4.3. France Market Size and Forecast (US$ Mn), 2015-2032 7.4.4. Spain Market Size and Forecast (US$ Mn), 2015-2032 7.4.5. Italy Market Size and Forecast (US$ Mn), 2015-2032 7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2015-2032 7.5. Revenue (US$ Mn) Comparison, By Process 7.6. Revenue (US$ Mn) Comparison, By Type 7.7. Revenue (US$ Mn) Comparison, By Drug Type 7.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 8. Japan Drug Discovery Services Market Size and Forecast, 2015-2032 8.1. Japan Outlook 8.2. Japan Parent Market Outlook 8.3. Japan Target Market Outlook 8.4. Revenue (US$ Mn) Comparison, By Country 8.4.1. Japan Market Size and Forecast (US$ Mn), 2015-2032 8.5. Revenue (US$ Mn) Comparison, By Process 8.6. Revenue (US$ Mn) Comparison, By Type 8.7. Revenue (US$ Mn) Comparison, By Drug Type 8.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 9. APEJ Drug Discovery Services Market Size and Forecast, 2015-2032 9.1. APEJ Outlook 9.2. APEJ Parent Market Outlook 9.3. APEJ Target Market Outlook 9.4. Revenue (US$ Mn) Comparison, By Country 9.4.1. China Market Size and Forecast (US$ Mn), 2015-2032 9.4.2. India Market Size and Forecast (US$ Mn), 2015-2032 9.4.3. Thailand Market Size and Forecast (US$ Mn), 2015-2032 9.4.4. Singapore Market Size and Forecast (US$ Mn), 2015-2032 9.4.5. Australia Market Size and Forecast (US$ Mn), 2015-2032 9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2015-2032 9.5. Revenue (US$ Mn) Comparison, By Process 9.6. Revenue (US$ Mn) Comparison, By Type 9.7. Revenue (US$ Mn) Comparison, By Drug Type 9.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 10. MEA Drug Discovery Services Market Size and Forecast, 2015-2032 10.1. MEA Outlook 10.2. MEA Parent Market Outlook 10.3. MEA Target Market Outlook 10.4. Revenue (US$ Mn) Comparison, By Country 10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2015-2032 10.4.2. South Africa Market Size and Forecast (US$ Mn), 2015-2032 10.4.3. Israel Market Size and Forecast (US$ Mn), 2015-2032 10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2015-2032 10.5. Revenue (US$ Mn) Comparison, By Process 10.6. Revenue (US$ Mn) Comparison, By Type 10.7. Revenue (US$ Mn) Comparison, By Drug Type 10.8. Revenue (US$ Mn) Comparison, By Therapeutic Area 11. Global Drug Discovery Services Market Company Share, Competition Landscape and Company Profiles 11.1. Company Share Analysis 11.2. Competition Landscape 11.3. Company Profiles 11.3.1. Thermo Fisher Scientific, Inc. 11.3.2. GE Healthcare 11.3.3. Charles River Laboratories International 11.3.4. Agilent Technologies, Inc. 11.3.5. Eli Lilly and Company 11.3.6. Lonza Group Ltd 11.3.7. WuXi AppTec Co. Ltd. 11.3.8. Evotec AG 11.3.9. Pharmaceutical Product Development LLC 11.3.10. Merck Millipore 11.3.11. Albany Molecular Research, Inc. 11.3.12. Covance Inc. 11.3.13. Genscript Biotech Corporation 11.3.14. Aurigene Discovery Technologies Limited 11.3.15. Syngene International Limited 11.3.16. Promega Corporation 11.3.17. SRI International, Inc. 11.3.18. Chembridge Corporation 11.3.19. GVK Biosciences Private Limited 11.3.20. Domainex Ltd. 11.3.21. Selcia Limited 11.3.22. Viva Biotech Ltd. 11.3.23. Jubilant Biosys Limited 11.3.24. Ubiquigent Limited 11.3.25. ReproCELL, Inc. 11.3.26. DiscoverX Corporation 11.3.27. Creative Bioarray 11.4. Key Takeaways 12. Research Methodology 13. Secondary and Primary Sources 14. Assumptions and Acronyms 15. Disclaimer
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
TABLE 1 Global Drug Discovery Services Market Value (US$ Mn), 2015-2021
TABLE 2 Global Drug Discovery Services Market Value (US$ Mn), 2022-2032
TABLE 3 Global Drug Discovery Services Market Value (US$ Mn) and Y-o-Y, 2022-2032
TABLE 4 Global Target Selection Segment Value (US$ Mn), By Region 2015-2021
TABLE 5 Global Target Selection Segment Value (US$ Mn), By Region 2022-2032
TABLE 6 Global Target Selection Segment Market Share, By Region 2015-2021
TABLE 7 Global Target Selection Segment Market Share, By Region 2022-2032
TABLE 8 Global Target Selection Segment Y-o-Y, By Region 2022-2032
TABLE 9 Global Target Validation Segment Value (US$ Mn), By Region 2015-2021
TABLE 10 Global Target Validation Segment Value (US$ Mn), By Region 2022-2032
TABLE 11 Global Target Validation Segment Market Share, By Region 2015-2021
TABLE 12 Global Target Validation Segment Market Share, By Region 2022-2032
TABLE 13 Global Target Validation Segment Y-o-Y, By Region 2022-2032
TABLE 14 Global Hit-To-Lead Identification Segment Value (US$ Mn), By Region 2015-2021
TABLE 15 Global Hit-To-Lead Identification Segment Value (US$ Mn), By Region 2022-2032
TABLE 16 Global Hit-To-Lead Identification Segment Market Share, By Region 2015-2021
TABLE 17 Global Hit-To-Lead Identification Segment Market Share, By Region 2022-2032
TABLE 18 Global Hit-To-Lead Identification Segment Y-o-Y, By Region 2022-2032
TABLE 19 Global Lead Optimization Segment Value (US$ Mn), By Region 2015-2021
TABLE 20 Global Lead Optimization Segment Value (US$ Mn), By Region 2022-2032
TABLE 21 Global Lead Optimization Segment Market Share, By Region 2015-2021
TABLE 22 Global Lead Optimization Segment Market Share, By Region 2022-2032
TABLE 23 Global Lead Optimization Segment Y-o-Y, By Region 2022-2032
TABLE 24 Global Candidate Validation Segment Value (US$ Mn), By Region 2015-2021
TABLE 25 Global Candidate Validation Segment Value (US$ Mn), By Region 2022-2032
TABLE 26 Global Candidate Validation Segment Market Share, By Region 2015-2021
TABLE 27 Global Candidate Validation Segment Market Share, By Region 2022-2032
TABLE 28 Global Candidate Validation Segment Y-o-Y, By Region 2022-2032
TABLE 29 Global Medicinal Chemistry Segment Value (US$ Mn), By Region 2015-2021
TABLE 30 Global Medicinal Chemistry Segment Value (US$ Mn), By Region 2022-2032
TABLE 31 Global Medicinal Chemistry Segment Market Share, By Region 2015-2021
TABLE 32 Global Medicinal Chemistry Segment Market Share, By Region 2022-2032
TABLE 33 Global Medicinal Chemistry Segment Y-o-Y, By Region 2022-2032
TABLE 34 Global Biology Services Segment Value (US$ Mn), By Region 2015-2021
TABLE 35 Global Biology Services Segment Value (US$ Mn), By Region 2022-2032
TABLE 36 Global Biology Services Segment Market Share, By Region 2015-2021
TABLE 37 Global Biology Services Segment Market Share, By Region 2022-2032
TABLE 38 Global Biology Services Segment Y-o-Y, By Region 2022-2032
TABLE 39 Global Drug Metabolism and Pharmacokinetics Segment Value (US$ Mn), By Region 2015-2021
TABLE 40 Global Drug Metabolism and Pharmacokinetics Segment Value (US$ Mn), By Region 2022-2032
TABLE 41 Global Drug Metabolism and Pharmacokinetics Segment Market Share, By Region 2015-2021
TABLE 42 Global Drug Metabolism and Pharmacokinetics Segment Market Share, By Region 2022-2032
TABLE 43 Global Drug Metabolism and Pharmacokinetics Segment Y-o-Y, By Region 2022-2032
TABLE 44 Global Small Molecules Segment Value (US$ Mn), By Region 2015-2021
TABLE 45 Global Small Molecules Segment Value (US$ Mn), By Region 2022-2032
TABLE 46 Global Small Molecules Segment Market Share, By Region 2015-2021
TABLE 47 Global Small Molecules Segment Market Share, By Region 2022-2032
TABLE 48 Global Small Molecules Segment Y-o-Y, By Region 2022-2032
TABLE 49 Global Biologics Segment Value (US$ Mn), By Region 2015-2021
TABLE 50 Global Biologics Segment Value (US$ Mn), By Region 2022-2032
TABLE 51 Global Biologics Segment Market Share, By Region 2015-2021
TABLE 52 Global Biologics Segment Market Share, By Region 2022-2032
TABLE 53 Global Biologics Segment Y-o-Y, By Region 2022-2032
TABLE 54 Global Oncology Segment Value (US$ Mn), By Region 2015-2021
TABLE 55 Global Oncology Segment Value (US$ Mn), By Region 2022-2032
TABLE 56 Global Oncology Segment Market Share, By Region 2015-2021
TABLE 57 Global Oncology Segment Market Share, By Region 2022-2032
TABLE 58 Global Oncology Segment Y-o-Y, By Region 2022-2032
TABLE 59 Global Neurology Segment Value (US$ Mn), By Region 2015-2021
TABLE 60 Global Neurology Segment Value (US$ Mn), By Region 2022-2032
TABLE 61 Global Neurology Segment Market Share, By Region 2015-2021
TABLE 62 Global Neurology Segment Market Share, By Region 2022-2032
TABLE 63 Global Neurology Segment Y-o-Y, By Region 2022-2032
TABLE 64 Global Cardiovascular Diseases Segment Value (US$ Mn), By Region 2015-2021
TABLE 65 Global Cardiovascular Diseases Segment Value (US$ Mn), By Region 2022-2032
TABLE 66 Global Cardiovascular Diseases Segment Market Share, By Region 2015-2021
TABLE 67 Global Cardiovascular Diseases Segment Market Share, By Region 2022-2032
TABLE 68 Global Cardiovascular Diseases Segment Y-o-Y, By Region 2022-2032
TABLE 69 Global Respiratory Diseases Segment Value (US$ Mn), By Region 2015-2021
TABLE 70 Global Respiratory Diseases Segment Value (US$ Mn), By Region 2022-2032
TABLE 71 Global Respiratory Diseases Segment Market Share, By Region 2015-2021
TABLE 72 Global Respiratory Diseases Segment Market Share, By Region 2022-2032
TABLE 73 Global Respiratory Diseases Segment Y-o-Y, By Region 2022-2032
TABLE 74 Global Diabetes Segment Value (US$ Mn), By Region 2015-2021
TABLE 75 Global Diabetes Segment Value (US$ Mn), By Region 2022-2032
TABLE 76 Global Diabetes Segment Market Share, By Region 2015-2021
TABLE 77 Global Diabetes Segment Market Share, By Region 2022-2032
TABLE 78 Global Diabetes Segment Y-o-Y, By Region 2022-2032
TABLE 79 Global Other Therapeutic Areas Segment Value (US$ Mn), By Region 2015-2021
TABLE 80 Global Other Therapeutic Areas Segment Value (US$ Mn), By Region 2022-2032
TABLE 81 Global Other Therapeutic Areas Segment Market Share, By Region 2015-2021
TABLE 82 Global Other Therapeutic Areas Segment Market Share, By Region 2022-2032
TABLE 83 Global Other Therapeutic Areas Segment Y-o-Y, By Region 2022-2032
TABLE 84 North America Current Expenditure on Health, (% of GDP), by Country, 2022-2032
TABLE 85 North America Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032
TABLE 86 North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032
TABLE 87 North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032
TABLE 88 North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032
TABLE 89 North America Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
TABLE 90 North America Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
TABLE 91 North America Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
TABLE 92 North America Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
TABLE 93 North America Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
TABLE 94 North America Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
TABLE 95 North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
TABLE 96 North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
TABLE 97 North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
TABLE 98 North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
TABLE 99 Latin America Current Expenditure on Health, (% of GDP), by Country, 2022-2032
TABLE 100 Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032
TABLE 101 Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032
TABLE 102 Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032
TABLE 103 Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032
TABLE 104 Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
TABLE 105 Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
TABLE 106 Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
TABLE 107 Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
TABLE 108 Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
TABLE 109 Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
TABLE 110 Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
TABLE 111 Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
TABLE 112 Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
TABLE 113 Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
TABLE 114 Europe Current Expenditure on Health, (% of GDP), by Country, 2022-2032
TABLE 115 Europe Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032
TABLE 116 Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032
TABLE 117 Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032
TABLE 118 Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032
TABLE 119 Europe Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
TABLE 120 Europe Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
TABLE 121 Europe Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
TABLE 122 Europe Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
TABLE 123 Europe Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
TABLE 124 Europe Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
TABLE 125 Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
TABLE 126 Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
TABLE 127 Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
TABLE 128 Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
TABLE 129 Japan Current Expenditure on Health, (% of GDP), by Country, 2022-2032
TABLE 130 Japan Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032
TABLE 131 Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032
TABLE 132 Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032
TABLE 133 Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032
TABLE 134 Japan Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
TABLE 135 Japan Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
TABLE 136 Japan Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
TABLE 137 Japan Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
TABLE 138 Japan Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
TABLE 139 Japan Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
TABLE 140 Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
TABLE 141 Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
TABLE 142 Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
TABLE 143 Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
TABLE 144 APEJ Current Expenditure on Health, (% of GDP), by Country, 2022-2032
TABLE 145 APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032
TABLE 146 APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032
TABLE 147 APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032
TABLE 148 APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032
TABLE 149 APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
TABLE 150 APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
TABLE 151 APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
TABLE 152 APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
TABLE 153 APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
TABLE 154 APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
TABLE 155 APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
TABLE 156 APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
TABLE 157 APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
TABLE 158 APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
TABLE 159 MEA Current Expenditure on Health, (% of GDP), by Country, 2022-2032
TABLE 160 MEA Per Capita Health Expenditure (US$ PPP), by Country, 2022-2032
TABLE 161 MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2022-2032
TABLE 162 MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2022-2032
TABLE 163 MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2022-2032
TABLE 164 MEA Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
TABLE 165 MEA Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
TABLE 166 MEA Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
TABLE 167 MEA Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
TABLE 168 MEA Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
TABLE 169 MEA Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
TABLE 170 MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
TABLE 171 MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
TABLE 172 MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
TABLE 173 MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
FIG. 1 Global Drug Discovery Services Market Value (US$ Mn), 2015-2021
FIG. 2 Global Drug Discovery Services Market Value (US$ Mn) Forecast, 2022-2032
FIG. 3 Global Drug Discovery Services Market Value (US$ Mn) and Y-o-Y, 2022-2032
FIG. 4 Global Target Selection Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 5 Global Target Selection Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 6 Global Target Selection Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 7 Global Target Validation Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 8 Global Target Validation Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 9 Global Target Validation Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 10 Global Hit-To-Lead Identification Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 11 Global Hit-To-Lead Identification Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 12 Global Hit-To-Lead Identification Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 13 Global Lead Optimization Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 14 Global Lead Optimization Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 15 Global Lead Optimization Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 16 Global Candidate Validation Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 17 Global Candidate Validation Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 18 Global Candidate Validation Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 19 Global Medicinal Chemistry Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 20 Global Medicinal Chemistry Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 21 Global Medicinal Chemistry Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 22 Global Biology Services Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 23 Global Biology Services Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 24 Global Biology Services Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 25 Global Drug Metabolism and Pharmacokinetics Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 26 Global Drug Metabolism and Pharmacokinetics Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 27 Global Drug Metabolism and Pharmacokinetics Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 28 Global Small Molecules Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 29 Global Small Molecules Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 30 Global Small Molecules Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 31 Global Biologics Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 32 Global Biologics Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 33 Global Biologics Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 34 Global Oncology Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 35 Global Oncology Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 36 Global Oncology Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 37 Global Neurology Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 38 Global Neurology Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 39 Global Neurology Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 40 Global Cardiovascular Diseases Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 41 Global Cardiovascular Diseases Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 42 Global Cardiovascular Diseases Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 43 Global Respiratory Diseases Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 44 Global Respiratory Diseases Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 45 Global Respiratory Diseases Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 46 Global Diabetes Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 47 Global Diabetes Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 48 Global Diabetes Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 49 Global Other Therapeutic Areas Segment Market Value (US$ Mn) By Region, 2015-2021
FIG. 50 Global Other Therapeutic Areas Segment Market Value (US$ Mn) By Region, 2022-2032
FIG. 51 Global Other Therapeutic Areas Segment Y-o-Y Growth Rate, By Region, 2022-2032
FIG. 52 North America Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
FIG. 53 North America Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
FIG. 54 North America Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
FIG. 55 North America Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
FIG. 56 North America Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
FIG. 57 North America Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
FIG. 58 North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
FIG. 59 North America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
FIG. 60 North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
FIG. 61 North America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
FIG. 62 Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
FIG. 63 Latin America Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
FIG. 64 Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
FIG. 65 Latin America Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
FIG. 66 Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
FIG. 67 Latin America Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
FIG. 68 Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
FIG. 69 Latin America Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
FIG. 70 Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
FIG. 71 Latin America Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
FIG. 72 Europe Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
FIG. 73 Europe Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
FIG. 74 Europe Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
FIG. 75 Europe Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
FIG. 76 Europe Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
FIG. 77 Europe Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
FIG. 78 Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
FIG. 79 Europe Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
FIG. 80 Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
FIG. 81 Europe Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
FIG. 82 Japan Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
FIG. 83 Japan Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
FIG. 84 Japan Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
FIG. 85 Japan Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
FIG. 86 Japan Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
FIG. 87 Japan Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
FIG. 88 Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
FIG. 89 Japan Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
FIG. 90 Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
FIG. 91 Japan Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
FIG. 92 APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
FIG. 93 APEJ Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
FIG. 94 APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
FIG. 95 APEJ Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
FIG. 96 APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
FIG. 97 APEJ Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
FIG. 98 APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
FIG. 99 APEJ Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
FIG. 100 APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
FIG. 101 APEJ Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
FIG. 102 MEA Drug Discovery Services Market Value (US$ Mn), By Country 2015-2021
FIG. 103 MEA Drug Discovery Services Market Value (US$ Mn), By Country 2022-2032
FIG. 104 MEA Drug Discovery Services Market Value (US$ Mn), By Process 2015-2021
FIG. 105 MEA Drug Discovery Services Market Value (US$ Mn), By Process 2022-2032
FIG. 106 MEA Drug Discovery Services Market Value (US$ Mn), By Type 2015-2021
FIG. 107 MEA Drug Discovery Services Market Value (US$ Mn), By Type 2022-2032
FIG. 108 MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2015-2021
FIG. 109 MEA Drug Discovery Services Market Value (US$ Mn), By Drug Type 2022-2032
FIG. 110 MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2015-2021
FIG. 111 MEA Drug Discovery Services Market Value (US$ Mn), By Therapeutic Area 2022-2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request